Piermont Valley Acquisition Corp
CMCAF
Analytical Summary
Piermont Valley Acquisition Corp shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.
18-Year Financial Trajectory
QuarterlyBullish Indicators
- Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
Bearish Risks
- No bearish risks detected.
Health Breakdown
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | Q4 FY2026 Mar 31, 2026 10-K ↗ | Q3 FY2026 Dec 31, 2025 10-Q ↗ | Q2 FY2026 Sep 30, 2025 10-Q ↗ | Q1 FY2026 Jun 30, 2025 10-Q ↗ | Q4 FY2025 Mar 31, 2025 10-K ↗ | Q3 FY2025 Dec 31, 2024 10-Q ↗ | Q2 FY2025 Sep 30, 2024 10-Q ↗ | Q1 FY2025 Jun 30, 2024 10-Q ↗ | Q4 FY2024 Dec 31, 2023 10-Q ↗ | Q3 FY2024 Dec 31, 2022 10-Q ↗ | Q2 FY2024 Sep 30, 2022 10-Q ↗ | Q1 FY2024 Jun 30, 2022 10-Q ↗ | Q4 FY2023 Mar 31, 2022 10-K ↗ | Q3 FY2023 Dec 31, 2021 10-Q ↗ | Q2 FY2023 Sep 30, 2021 10-Q ↗ | Q1 FY2023 Mar 31, 2022 10-Q ↗ | Q4 FY2022 Apr 19, 2021 10-K ↗ | Q1 FY2022 Apr 19, 2021 10-Q ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Growth YoY (%) | N/M | N/M | N/M | N/M | — |
-72.2%
Weak
→
Weak
Stable
Year-over-year change in net income |
-72.2%
Weak
Weak
Year-over-year change in net income |
-72.2%
Weak
Weak
Year-over-year change in net income |
— | N/M | N/M | N/M | — | — | — | — | — | — |
| Metric | Q4 FY2026 Mar 31, 2026 10-K ↗ | Q3 FY2026 Dec 31, 2025 10-Q ↗ | Q2 FY2026 Sep 30, 2025 10-Q ↗ | Q1 FY2026 Jun 30, 2025 10-Q ↗ | Q4 FY2025 Mar 31, 2025 10-K ↗ | Q3 FY2025 Dec 31, 2024 10-Q ↗ | Q2 FY2025 Sep 30, 2024 10-Q ↗ | Q1 FY2025 Jun 30, 2024 10-Q ↗ | Q4 FY2024 Dec 31, 2023 10-Q ↗ | Q3 FY2024 Dec 31, 2022 10-Q ↗ | Q2 FY2024 Sep 30, 2022 10-Q ↗ | Q1 FY2024 Jun 30, 2022 10-Q ↗ | Q4 FY2023 Mar 31, 2022 10-K ↗ | Q3 FY2023 Dec 31, 2021 10-Q ↗ | Q2 FY2023 Sep 30, 2021 10-Q ↗ | Q1 FY2023 Mar 31, 2022 10-Q ↗ | Q4 FY2022 Apr 19, 2021 10-K ↗ | Q1 FY2022 Apr 19, 2021 10-Q ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FCF / Net Income (x) |
0.29x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
0.05x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.02x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
0.03x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.17x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.10x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.12x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.25x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — | — |
-0.12x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.02x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
59.12x
Excellent
Excellent
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — | — | — |
| Metric | Q4 FY2026 Mar 31, 2026 10-K ↗ | Q3 FY2026 Dec 31, 2025 10-Q ↗ | Q2 FY2026 Sep 30, 2025 10-Q ↗ | Q1 FY2026 Jun 30, 2025 10-Q ↗ | Q4 FY2025 Mar 31, 2025 10-K ↗ | Q3 FY2025 Dec 31, 2024 10-Q ↗ | Q2 FY2025 Sep 30, 2024 10-Q ↗ | Q1 FY2025 Jun 30, 2024 10-Q ↗ | Q4 FY2024 Dec 31, 2023 10-Q ↗ | Q3 FY2024 Dec 31, 2022 10-Q ↗ | Q2 FY2024 Sep 30, 2022 10-Q ↗ | Q1 FY2024 Jun 30, 2022 10-Q ↗ | Q4 FY2023 Mar 31, 2022 10-K ↗ | Q3 FY2023 Dec 31, 2021 10-Q ↗ | Q2 FY2023 Sep 30, 2021 10-Q ↗ | Q1 FY2023 Mar 31, 2022 10-Q ↗ | Q4 FY2022 Apr 19, 2021 10-K ↗ | Q1 FY2022 Apr 19, 2021 10-Q ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Common Equity (%) (%) |
31.3%
Excellent
↓
Excellent
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Above avg (+161%)
|
89.7%
Excellent
↑
Excellent
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Above avg (+648%)
|
120.2%
Excellent
↑
Excellent
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Above avg (+902%)
|
30.4%
Excellent
Excellent
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Above avg (+153%)
|
-42.3%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-453%)
|
— | — | — | — |
-17.8%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-249%)
|
-15.5%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-229%)
|
-16.3%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-236%)
|
-53.2%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-544%)
|
— | — |
-73.7%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-714%)
|
— | — |
| Metric | Q4 FY2026 Mar 31, 2026 10-K ↗ | Q3 FY2026 Dec 31, 2025 10-Q ↗ | Q2 FY2026 Sep 30, 2025 10-Q ↗ | Q1 FY2026 Jun 30, 2025 10-Q ↗ | Q4 FY2025 Mar 31, 2025 10-K ↗ | Q3 FY2025 Dec 31, 2024 10-Q ↗ | Q2 FY2025 Sep 30, 2024 10-Q ↗ | Q1 FY2025 Jun 30, 2024 10-Q ↗ | Q4 FY2024 Dec 31, 2023 10-Q ↗ | Q3 FY2024 Dec 31, 2022 10-Q ↗ | Q2 FY2024 Sep 30, 2022 10-Q ↗ | Q1 FY2024 Jun 30, 2022 10-Q ↗ | Q4 FY2023 Mar 31, 2022 10-K ↗ | Q3 FY2023 Dec 31, 2021 10-Q ↗ | Q2 FY2023 Sep 30, 2021 10-Q ↗ | Q1 FY2023 Mar 31, 2022 10-Q ↗ | Q4 FY2022 Apr 19, 2021 10-K ↗ | Q1 FY2022 Apr 19, 2021 10-Q ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt to Equity (x) | — | — | — | — | — | — | — | — |
-0.06x
Excellent
Excellent
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-105%)
|
— | — | — | — | — | — | — | — | — |
| Net Debt (USD) | $-2.46M | $-53.17K | $-14.50K | $0.00 | $-2.38M | — | — | — | $588.80K | $-260.14K | $-425.60K | $-784.00K | $-90.28K | — | — | $-783.77K | — | — |
| Metric | Q4 FY2026 Mar 31, 2026 10-K ↗ | Q3 FY2026 Dec 31, 2025 10-Q ↗ | Q2 FY2026 Sep 30, 2025 10-Q ↗ | Q1 FY2026 Jun 30, 2025 10-Q ↗ | Q4 FY2025 Mar 31, 2025 10-K ↗ | Q3 FY2025 Dec 31, 2024 10-Q ↗ | Q2 FY2025 Sep 30, 2024 10-Q ↗ | Q1 FY2025 Jun 30, 2024 10-Q ↗ | Q4 FY2024 Dec 31, 2023 10-Q ↗ | Q3 FY2024 Dec 31, 2022 10-Q ↗ | Q2 FY2024 Sep 30, 2022 10-Q ↗ | Q1 FY2024 Jun 30, 2022 10-Q ↗ | Q4 FY2023 Mar 31, 2022 10-K ↗ | Q3 FY2023 Dec 31, 2021 10-Q ↗ | Q2 FY2023 Sep 30, 2021 10-Q ↗ | Q1 FY2023 Mar 31, 2022 10-Q ↗ | Q4 FY2022 Apr 19, 2021 10-K ↗ | Q1 FY2022 Apr 19, 2021 10-Q ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Working Capital (USD) | $-325.47K | $-180.54K | $-161.39K | $-2.03M | $-1.99M | — | — | — | $-1.19M | $-81.89K | $188.20K | $1.01M | $1.27M | — | — | $1.27M | — | — |
| Total Equity (USD) | $-1.48M | $-999.54K | $-746.39K | $-2.96M | $-2.04M | — | — | — | $-12.02M | $-9.01M | $-10.38M | $-9.86M | $-11.16M | — | — | $14.39K | $0.00 | $0.00 |
| Metric | Q4 FY2026 Mar 31, 2026 10-K ↗ | Q3 FY2026 Dec 31, 2025 10-Q ↗ | Q2 FY2026 Sep 30, 2025 10-Q ↗ | Q1 FY2026 Jun 30, 2025 10-Q ↗ | Q4 FY2025 Mar 31, 2025 10-K ↗ | Q3 FY2025 Dec 31, 2024 10-Q ↗ | Q2 FY2025 Sep 30, 2024 10-Q ↗ | Q1 FY2025 Jun 30, 2024 10-Q ↗ | Q4 FY2024 Dec 31, 2023 10-Q ↗ | Q3 FY2024 Dec 31, 2022 10-Q ↗ | Q2 FY2024 Sep 30, 2022 10-Q ↗ | Q1 FY2024 Jun 30, 2022 10-Q ↗ | Q4 FY2023 Mar 31, 2022 10-K ↗ | Q3 FY2023 Dec 31, 2021 10-Q ↗ | Q2 FY2023 Sep 30, 2021 10-Q ↗ | Q1 FY2023 Mar 31, 2022 10-Q ↗ | Q4 FY2022 Apr 19, 2021 10-K ↗ | Q1 FY2022 Apr 19, 2021 10-Q ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income, GAAP (USD) | $-462.16K | $-897.04K | $-897.04K | $-897.04K | $861.74K | $446.62K | $446.62K | $446.62K | — | $1.61M | $1.61M | $1.61M | $5.94M | $-10.61K | $-10.61K | $-10.61K | — | — |
| Operating Cash Flow (USD) | $-133.35K | $-45.48K | $15.63K | $-25.61K | $-148.99K | $-43.51K | $-55.36K | $-110.51K | — | — | — | $-185.49K | $-126.28K | $-627.05K | — | — | — | — |
Secondary lens
Benchmark Lens
Compare CMCAF against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare CMCAF against peers after checking the statement evidence.
Signals
Key bullish and bearish indicators for CMCAF
Return on Common Equity (%) is in the top quartile
No bearish signals detected
Percentile Rankings
How CMCAF compares to all companies
Compare CMCAF with peers
Stack CMCAF against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 5 years · 18 quarters